Zentalis Pharmaceuticals (ZNTL) PT Lowered to $4 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Price: $4.15 -3.26%
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Zentalis Pharmaceuticals (NASDAQ: ZNTL) to $4.00 (from $8.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Legence Corp (LGN) PT Lowered to $100 at BTIG
- Zentalis Pharmaceuticals launches public stock offering
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
